There's Still a Big EpiPen Shortage—But Walgreens Will Start Selling a Competing Product Kaleo's allergy shot Auvi-Q will reportedly be free for those with commerci... Kaleo's allergy shot Auvi-Q will reportedly be free for those with commercial insurance.
The FDA Finally Approved an EpiPen Generic. But a Shortage Looms Ahead of the School Year Manufacturing woes have led to a big EpiPen shortage even as the agency cle... Manufacturing woes have led to a big EpiPen shortage even as the agency clears a new generic.
Pfizer's Meridian Hit With FDA Warning Over EpiPen Flaws Warning comes with threat of legal action. Warning comes with threat of legal action.
EpiPen Maker Mylan Saves Millions in Taxes Thanks to Huge Stakes in Coal Companies It's a unique arrangement for a drug maker, according to a Reuters report. It's a unique arrangement for a drug maker, according to a Reuters report.
Will the Newest EpiPen Competitor Steal Even More Market Share from Mylan? The FDA just approved Adamis Pharma's rival Symjepi. The FDA just approved Adamis Pharma's rival Symjepi.
Mylan Shareholders Are Being Advised to Vote Against Board Members and Executive Pay Packages Influential proxy firm ISS is the latest high-profile group making the reco... Influential proxy firm ISS is the latest high-profile group making the recommendation.
Mylan's Shareholders Fight to Dump Its Board After the Epipen Scandal Chairman Robert Coury, in particular, is in the firing line Chairman Robert Coury, in particular, is in the firing line